Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 79,978,672 | reported | 27 Mar 2018 | tx 2+6,571,164 |
| INTERLEUKIN GENETICS INC | 35,298,087 | reported | 23 Dec 2014 | tx 2+39,737,930 |
| Casper Sleep Inc. | 6,222,412 | reported | 10 Feb 2020 | tx 1+1,250,000 |
| Mersana Therapeutics, Inc. | 5,959,520 | reported | 14 Sept 2020 | tx 3+20,000−2,020,000 |
| Enliven Therapeutics, Inc. | 3,488,264 | reported | 11 Jan 2022 | tx 3−18,760 |
| Tracon Pharmaceuticals, Inc. | 3,466,003 | reported | 27 Mar 2018 | tx 9+6,533,277 |
| L&F Acquisition Corp. | 0 | reported | 13 May 2024 | tx 1−18,068,513 |
| APPIAN CORP | 0 | reported | 27 Nov 2017 | tx 5+6,683,958−7,253,578 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 May 2024 | TENDER | L&F Acquisition Corp. | 18,068,513 | — | |
| 07 Jan 2022 | SALE | Enliven Therapeutics, Inc. | 14,600 | 2.08 USD | |
| 10 Jan 2022 | SALE | Enliven Therapeutics, Inc. | 1,751 | 2.00 USD | |
| 11 Jan 2022 | SALE | Enliven Therapeutics, Inc. | 2,409 | 2.04 USD | |
| 14 Sept 2020 | OTHER | Mersana Therapeutics, Inc. | 2,000,000 | 0.00 USD | |
| 14 Sept 2020 | OTHER | Mersana Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 14 Sept 2020 | OTHER | Mersana Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 10 Feb 2020 | PURCHASE | Casper Sleep Inc. | 1,250,000 | 12.00 USD | first after silence |
| 26 Mar 2018 | PURCHASE | Adaptimmune Therapeutics PLC | 571,164 | 1.90 USD | first after silence |
| 27 Mar 2018 | PURCHASE | Adaptimmune Therapeutics PLC | 6,000,000 | 1.92 USD | |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 2.70 USD | |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 0.13 USD | deriv |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 2.70 USD | |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 0.13 USD | deriv |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 2.70 USD | |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 0.13 USD | deriv |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 2.70 USD | |
| 27 Mar 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 707,964 | 0.13 USD | deriv |
| 27 Nov 2017 | SALE | APPIAN CORP | 569,620 | 19.49 USD | |
| 27 Nov 2017 | CONVERSION | APPIAN CORP | 569,620 | — | |
| 27 Nov 2017 | CONVERSION | APPIAN CORP | 569,620 | 0.00 USD | deriv |
| 31 May 2017 | CONVERSION | APPIAN CORP | 6,114,338 | 0.00 USD | deriv |
| 31 May 2017 | CONVERSION | APPIAN CORP | 6,114,338 | 0.00 USD | deriv |
| 29 Nov 2016 | PURCHASE | Tracon Pharmaceuticals, Inc. | 869,565 | 5.75 USD | first after silence |
| 23 Dec 2014 | PURCHASE | INTERLEUKIN GENETICS INC | 19,868,965 | 0.10 USD |
3 purchases reported after at least 12 months of silence — most recent on 10 Feb 2020.